top of page

Stanford Glomerular Disease Center

GN_photo_Clinical6_0001.jpg

Overview

Our glomerular disease clinic embraces all glomerular diseases patients, utilizing cutting edge diagnostics and therapeutics, spanning primary disease (IgAN, membranous, FSGS, minimal change, C3GN, ICGN, fibrillary) to systemic (ANCA- related, anti-GBM related, lupus nephritis, light chain disease related, infection related, drug/toxin related and cancer related). We counsel and treat women with pregnancy related issues regarding glomerular disease as well. We emphasize clinical trials as an option for all of our patients and encourage patients to join disease support groups and registries.

300 Pasteur Drive, Stanford, CA 94305

Richard Lafayette, M.D.
Clinic: 650-723-6961
Research: 650-736-1866

Director

Richard Lafayette, M.D.

Fahmeedah Kamal, M.D.
Jackson Kim, M.D.

Neuropathologists

Neeraja Khambam, M.D.
Vivek Charu, M.D.
Jonathan Higgins, M.D.
Meghan Troxell, M.D.

Current active clinical trials:

Zanabrutinib membranous nephropathy trial
REBOOT membranous nephropathy trial
Obinutuzumab Lupus nephritis trial
Ravulizumab lupus nephritis trial
AFFINITY atrasentan FSGS trial
ALIGN atrasentan IgA nephropathy trial
sparsentan IgA nepropathy PROTECT trial
atacicept igA nephropathy ORIGIN trial
sibeprenlimab IgA Visionary nephropathy trial

Current non-trial studies

NEPTUNE cohort study (FSGS, ALports, Minimal change, membranous nephropathy)
CURE GN study (FSGS, IgA nephropathy)
Minimal change (membranous nephropathy)
Trident cohort study (diabetic nephropathy)

Accepting trainee applications?

Yes, have GN fellowship, 1 year mixed clinical and research

bottom of page